Cecchini MA, et al. - The clinicians examined whether free recall deficits during short-term memory binding (STMB) test could differentiate patients with Alzheimer’s disease (AD) from those with behavioral variant frontotemporal dementia (bvFTD) and controls. In this present study, they supported the view that the STMB could be a suitable cognitive marker for AD.